Effects of a synbiotic yogurt using monk fruit extract as sweetener on glucose regulation and gut microbiota in rats with type 2 diabetes mellitus

被引:37
作者
Ban, Qingfeng [1 ,2 ]
Cheng, Jianjun [1 ]
Sun, Xiaomeng [1 ]
Jiang, Yunqing [1 ,2 ]
Zhao, Shanbo [1 ,2 ]
Song, Xiao [1 ,2 ]
Guo, Mingruo [2 ,3 ]
机构
[1] Northeast Agr Univ, Coll Food Sci, Harbin 150030, Peoples R China
[2] Northeast Agr Univ, Key Lab Dairy Sci, Minist Educ, Harbin 150030, Peoples R China
[3] Univ Vermont, Coll Agr & Life Sci, Dept Nutr & Food Sci, Burlington, VT 05405 USA
关键词
synbiotic yogurt; monk fruit extract; gut microbiota; type 2 diabetes mellitus; MOGROSIDE V; CARDIOVASCULAR-DISEASE; SIRAITIA-GROSVENORI; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; CELL-FUNCTION; IN-VITRO; OLIGOSACCHARIDES; ASSOCIATION;
D O I
10.3168/jds.2019-17700
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
We developed a synbiotic yogurt using monk fruit extract as a sweetener and investigated the effects of feeding the yogurt to rats with type 2 diabetes induced by streptozotocin and a high-fat diet. The rats fed the synbiotic yogurt showed greater blood glucose regulation and a significant decrease in insulin resistance and glycosylated hemoglobin compared with rats fed yogurt sweetened with sucrose, and they showed a remarkable improvement in short-chain fatty acid levels and gut microbiota status. Liver and kidney damage was also ameliorated in the rats fed the synbiotic yogurt. Immunohistochemistry analysis showed that the synbiotic yogurt inhibited beta-cell loss compared with the control yogurt. Consuming the synbiotic yogurt helped to restore the islets of Langerhans. Our results indicated that monk fruit extract may be a good alternative to sucrose for synbiotic yogurt products in people with type 2 diabetes to delay the progression of diabetes and associated complications.
引用
收藏
页码:2956 / 2968
页数:13
相关论文
共 54 条
  • [1] Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
    Ali, Safina
    Drucker, Daniel J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (03): : E415 - E421
  • [2] [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1
  • [3] [Anonymous], SCI REP UK
  • [4] [Anonymous], YOG PLAIN WHOL MILK
  • [5] [Anonymous], 2010, J GUANGXI TRADIT CHI
  • [6] Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance An Early Contributor to Diabetes-Related Vascular Disease?
    Bender, Shawn B.
    McGraw, Adam P.
    Jaffe, Iris Z.
    Sowers, James R.
    [J]. DIABETES, 2013, 62 (02) : 313 - 319
  • [7] Gut microbiota and probiotics: Focus on diabetes mellitus
    Bordalo Tonucci, Livia
    Dos Santos, Karina Maria Olbrich
    De Luces Fortes Ferreira, Celia Lucia
    Rocha Ribeiro, Sonia Machado
    De Oliveira, Leandro Licursi
    Duarte Martino, Hercia Stampini
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2017, 57 (11) : 2296 - 2309
  • [8] Chakrabarti R, 2002, CURR SCI INDIA, V83, P1533
  • [9] γ-Aminobutyric acid-rich yogurt fermented by Streptococcus salivarius subsp thermophiles fmb5 apprars to have anti-diabetic effect on streptozotocin-induced diabetic mice
    Chen, Lin
    Zhao, Haizhen
    Zhang, Chong
    Lu, Yingjian
    Zhu, Xiaoyu
    Lu, Zhaoxin
    [J]. JOURNAL OF FUNCTIONAL FOODS, 2016, 20 : 267 - 275
  • [10] Chen WeiJun Chen WeiJun, 2006, Acta Nutrimenta Sinica, V28, P221